A single intra-articular dose of Fx006, an extended-release formulation of triamcinolone acetonide, has a similar effect on cartilage in healthy dogs as the commonly used kenalog-40® suspension

Healthy Dogs

Sustained and profound analgesic benefits in people with osteoarthritis of the knee using FX006, an intra-articular extended-release formulation of triamcinolone acetonide: Results from a double-blind, randomized, parallel-group, dose-ranging study

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2016.01.113 ◽

2016 ◽

Vol 24 ◽

pp. S49-S50 ◽

Author(s):

P.G. Conaghan ◽

S. Cohen ◽

J. Jordan ◽

F. Berenbaum ◽

J. Lufkin ◽

...

Keyword(s):

Triamcinolone Acetonide ◽

Extended Release ◽

Osteoarthritis Of The Knee ◽

Double Blind ◽

Release Formulation ◽

Parallel Group ◽

Dose Ranging

Synovial and systemic pharmacokinetics of triamcinolone acetonide following intra-articular injection of an extended release formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis

Osteoarthritis and Cartilage ◽

10.1016/j.joca.2017.02.744 ◽

2017 ◽

Vol 25 ◽

pp. S431 ◽

Cited By ~ 2

Author(s):

V. Byers-Kraus ◽

H.A. Aazami ◽

P. Mehra ◽

A.J. Kivitz ◽

J. Lufkin ◽

...

Keyword(s):

Knee Osteoarthritis ◽

Triamcinolone Acetonide ◽

Extended Release ◽

Release Formulation ◽

Crystalline Suspension

An Intra-Articular, Extended-Release Formulation of Triamcinolone Acetonide Prolongs and Amplifies Analgesic Effect in Patients with Osteoarthritis of the Knee

The Journal of Bone and Joint Surgery (American) ◽

10.2106/jbjs.n.00918 ◽

2015 ◽

Vol 97 (11) ◽

pp. 877-888 ◽

Cited By ~ 58

Author(s):

Neil Bodick ◽

Joelle Lufkin ◽

Christina Willwerth ◽

Anjali Kumar ◽

James Bolognese ◽

...

Keyword(s):

Triamcinolone Acetonide ◽

Analgesic Effect ◽

Extended Release ◽

Osteoarthritis Of The Knee ◽

Release Formulation ◽

Extended-release Formulation Attenuates the Impacts of Fluvastatin on Serum PCSK9 Levels in Humans

Letters in Drug Design & Discovery ◽

10.2174/1570180814666161216121558 ◽

2017 ◽

Vol 14 (7) ◽

Author(s):

Yuan-Lin Guo ◽

Wei Zhang ◽

Qian Dong ◽

Geng Liu ◽

Cheng-Gang Zhu ◽

...

Keyword(s):

Extended Release ◽

Release Formulation ◽

A Comparison of the Pharmacokinetics of Methylphenidate Extended-Release Orally Disintegrating Tablets With a Reference Extended-Release Formulation of Methylphenidate in Healthy Adults

Clinical Pharmacology in Drug Development ◽

10.1002/cpdd.362 ◽

2017 ◽

Vol 7 (2) ◽

pp. 151-159 ◽

Author(s):

Ann Childress ◽

Jeffrey G. Stark ◽

Russ McMahen ◽

Dorothy Engelking ◽

Carolyn Sikes

Keyword(s):

Extended Release ◽

Healthy Adults ◽

Release Formulation ◽

Orally Disintegrating Tablets

Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation

European Journal of Pharmaceutics and Biopharmaceutics ◽

10.1016/j.ejpb.2010.11.024 ◽

2011 ◽

Vol 77 (2) ◽

pp. 306-312 ◽

Cited By ~ 19

Author(s):

L. Ochoa ◽

M. Igartua ◽

R.M. Hernández ◽

A.R. Gascón ◽

M.A. Solinis ◽

...

Keyword(s):

Extended Release ◽

In Vivo Evaluation ◽

Release Formulation ◽

One Step ◽

Melt Granulation

IMPURITY PROFILING OF THE ROPINIROLE EXTENDED RELEASE FORMULATION, IDENTIFICATION AND CHARACTERIZATION OF POTENTIAL DEGRADANT

Journal of Liquid Chromatography &amp Related Technologies ◽

10.1080/10826076.2013.850720 ◽

2014 ◽

Vol 37 (17) ◽

pp. 2490-2505 ◽

Author(s):

Palavai Sripal Reddy ◽

A. Malleswara Reddy ◽

S. Jayapal Reddy ◽

Shakil Sait ◽

K. Vyas

Keyword(s):

Extended Release ◽

Release Formulation ◽

Identification And Characterization

Impurity Profiling ◽

Fluvastatin extended-release formulation is effective in treating primary hypercholesterolaemia

Atherosclerosis ◽

10.1016/s0021-9150(00)80341-x ◽

2000 ◽

Vol 151 (1) ◽

pp. 74-75 ◽

Author(s):

W Insull ◽

A.D Marais ◽

R Aronson ◽

S Manfreda

Keyword(s):

Extended Release ◽

Release Formulation ◽

Primary Hypercholesterolaemia ◽

Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment

International Journal of Pharmaceutics ◽

10.1016/j.ijpharm.2021.120329 ◽

2021 ◽

Vol 597 ◽

pp. 120329

Author(s):

Manali Patki ◽

Siddhant Palekar ◽

Sandra Reznik ◽

Ketan Patel

Keyword(s):

Extended Release ◽

Release Formulation ◽

Potential Formulation

The Abuse Potential of Remoxy®, an Extended-Release Formulation of Oxycodone, Compared with Immediate- and Extended-Release Oxycodone

Pain Medicine ◽

10.1111/j.1526-4637.2011.01093.x ◽

2011 ◽

Vol 12 (4) ◽

pp. 618-631 ◽

Cited By ~ 34

Author(s):

Beatrice Setnik ◽

Carl L. Roland ◽

Jody M. Cleveland ◽

Lynn Webster

Keyword(s):

Extended Release ◽

Abuse Potential ◽

Release Formulation ◽